Company

Achieve Life Sciences, Inc.

Headquarters: Vancouver, BC, Canada

Employees: 16

CEO: Mr. John A. Bencich

NASDAQ: ACHV -0.66%

Market Cap

$155.9 Million

USD as of July 1, 2024

Market Cap History

Achieve Life Sciences, Inc. market capitalization over time

Evolution of Achieve Life Sciences, Inc. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Achieve Life Sciences, Inc.

Detailed Description

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Achieve Life Sciences, Inc. has the following listings and related stock indices.


Stock: NASDAQ: ACHV wb_incandescent

Stock: FSX: SP4P wb_incandescent

Details

Headquarters:

1040 West Georgia Street

Suite 1030

Vancouver, BC V6E 4H1

Canada

Phone: 604 210 2217